![Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof](/docs/US/2019-02-26/US10214526B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
-
Application No.: US15548158Application Date: 2016-02-02
-
Publication No.: US10214526B2Publication Date: 2019-02-26
- Inventor: Alexandros Vakalopoulos , Damian Brockschnieder , Frank Wunder , Johannes-Peter Stasch , Tobias Marquardt , Lisa Dietz , Min Jian Volkhart Li
- Applicant: Bayer Pharma Aktiengesellschaft
- Applicant Address: DE Berlin
- Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee: Bayer Pharma Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Agency: Ice Miller LLP
- Priority: EP15153958 20150205
- International Application: PCT/EP2016/052126 WO 20160202
- International Announcement: WO2016/124565 WO 20160811
- Main IPC: C07D471/04
- IPC: C07D471/04
![Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof](/abs-image/US/2019/02/26/US10214526B2/abs.jpg.150x150.jpg)
Abstract:
The present application relates to novel substituted pyrazolo[1,5-a]pyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Public/Granted literature
- US20180037580A1 Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof Public/Granted day:2018-02-08
Information query
